Domestic manufacturing, stable procurement, transportation cost reduction | Contract manufacturing of liquid media in compliance with GMP
In the pharmaceutical industry, particularly in the quality control department, the quality of the liquid media used for cell culture is a crucial factor that influences the safety and efficacy of products. Media manufactured in a GMP-compliant environment is essential to minimize the risk of contamination and ensure the reliability of test results. Our services provide sterile filling into containers tailored to customer requirements in a GMP-compliant manufacturing environment, supporting solutions to challenges in quality control. 【Usage Scenarios】 - Procurement of media in the cell culture process - Stabilization of media quality in the quality control department - Transition from research and development to clinical trials 【Benefits of Implementation】 - Quality assurance through GMP compliance - Increased efficiency in research and development due to stable supply - Cost reduction and shortened delivery times
Inquire About This Product
basic information
**Features** - Manufacturing environment compliant with GMP - Production line capable of handling small quantities and a variety of products - Strict raw material management - Aseptic filling into containers tailored to customer requests - Consultation available for implementation audits **Our Strengths** We contribute to the field of regenerative medicine by merging high-quality amino acid-based culture media ingredients with advanced production technology as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Ltd. Our manufacturing system complies with GMP, and we are capable of flexible responses tailored to customer needs.
Price information
Please contact us separately.
Delivery Time
※It will vary depending on the quantity, so please contact us separately.
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog（3）
Download All Catalogs
Company information
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.
![[Research Material] Global Market for 5-Chloro-2-Hydroxybenzoic Acid](https://image.mono.ipros.com/public/product/image/0b2/2001480869/IPROS60500409501541094105.jpeg?w=280&h=280)
